WASHINGTON – The government approved a drug Tuesday that tries a new method of attacking multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans. The drug – a monoclonal antibody produced by Cambridge, Mass.-based Biogen Idec Inc. and Irish drug… Read More
Comments for: FDA OKs new drug for multiple sclerosis
FDA OKs new drug for multiple sclerosis
You may also like
FDA OKs new drug for multiple sclerosis